COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up

A Tajbakhsh, SM Gheibi Hayat… - Expert review of anti …, 2021 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has the characteristics of
high transmission, diverse clinical manifestations, and a long incubation period. In addition …

Administration of COVID-19 vaccines in immunocompromised patients

M Negahdaripour, M Shafiekhani, SMI Moezzi… - International …, 2021 - Elsevier
Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

Nanocarrier vaccines for SARS-CoV-2

J Machhi, F Shah**, S Das, M Patel… - Advanced Drug Delivery …, 2021 - Elsevier
The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death
associated with substantive social, economic and societal impacts. Treatments rely on re …

SARS-CoV-2/COVID-19 and advances in develo** potential therapeutics and vaccines to counter this emerging pandemic

AA Rabaan, SH Al-Ahmed, R Sah, R Tiwari… - Annals of Clinical …, 2020 - Springer
A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19),
first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with …

Experience in multiple sclerosis patients with COVID-19 and disease-modifying therapies: a review of 873 published cases

N Möhn, FF Konen, R Pul, C Kleinschnitz… - Journal of clinical …, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic is a
challenge for all participants in the healthcare system. At the beginning of the pandemic …

Cell penetrating peptide: A potent delivery system in vaccine development

B Hasannejad-Asl, F Pooresmaeil… - Frontiers in …, 2022 - frontiersin.org
One of the main obstacles to most medication administrations (such as the vaccine
constructs) is the cellular membrane's inadequate permeability, which reduces their …

[HTML][HTML] Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines

I Sadeghian, R Heidari, S Sadeghian, MJ Raee… - European Journal of …, 2022 - Elsevier
Viral infections are a great threat to human health. Currently, there are no effective vaccines
and antiviral drugs against the majority of viral diseases, suggesting the need to develop …

Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity

JK Chaudhary, R Yadav, PK Chaudhary, A Maurya… - Cells, 2021 - mdpi.com
The first quarter of the 21st century has remarkably been characterized by a multitude of
challenges confronting human society as a whole in terms of several outbreaks of infectious …

Interferon-inducer antivirals: Potential candidates to combat COVID-19

A Bagheri, SMI Moezzi, P Mosaddeghi… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infective disease generated by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given the pandemic urgency and …

Immunotherapies and immunomodulatory approaches in clinical trials-a mini review

M Iqbal Yatoo, Z Hamid, I Rather… - Human vaccines & …, 2021 - Taylor & Francis
ABSTRACT The coronavirus disease (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the …